Back to results
US 2025/0375384 A1Published application
Soft dual chambered liquid-gel capsule and method to deliver sublingual and ingestible cannabis compositions
AssigneeHealthy Option Consulting Inc.
InventorAndrew Farber
Life of this patent
Estimating the term…
Abstract
Provided is a dual chambered liquid-gel capsule 1 having a first chamber 2 containing a sublingual cannabis composition 10 and a second chamber 4 containing an ingestible cannabis composition 12. Also provided is a method of administering the cannabis compositions to a patient in need of the cannabis compositions using the dual chambered liquid-gel capsule.
Claims10
1-7. (canceled)
A method for supplying a cannabis product to a patient in need of the cannabis product comprising:
- providing a soft liquid-gel capsule comprising a first enclosed chamber and a second enclosed chamber, a sublingual cannabis composition contained solely within the first enclosed chamber, and an ingestible cannabis composition contained solely within the second enclosed chamber, a soft-gel wall separating the first enclosed chamber from the second enclosed chamber;
- piercing the first enclosed chamber and flowing the sublingual cannabis composition into the patient's mouth and under the patient's tongue;
- swallowing the second enclosed chamber;
- and
- allowing the second enclosed chamber to dissolve or break open in the patient's stomach or small intestine to release the oral cannabis composition into the digestive tract.
2 more elements
A method for supplying a cannabis product to a patient in need of the cannabis product comprising:
- providing an elongated soft liquid-gel capsule comprising a first enclosed chamber having a first bullet shape and a second enclosed chamber having a second bullet shape, a sublingual cannabis composition contained solely within the first enclosed chamber, and an ingestible cannabis composition contained solely within the second enclosed chamber, a soft-gel wall separating the first enclosed chamber from the second enclosed chamber;
- piercing the first enclosed chamber and flowing the sublingual cannabis composition into the patient's mouth and under the patient's tongue;
- swallowing the second enclosed chamber;
- and
- allowing the second enclosed chamber to dissolve or break open in the patient's stomach or small intestine to release the oral cannabis composition into the digestive tract.
2 more elements
Dependencies are inferred from the claim text.